These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4472802)

  • 1. Synthesis and biological activity of some aporphine derivatives related to apomorphine.
    Saari WS; King SW
    J Med Chem; 1974 Oct; 17(10):1086-90. PubMed ID: 4472802
    [No Abstract]   [Full Text] [Related]  

  • 2. Aporphines, 21. (1,2) Dopaminergic activity of aporphine and benzylisoquinoline derivatives. Synthesis of 8-hydroxyaporphines and 1-(hydroxybenzyl)-2-n-propyl-1,2,3,4-tetrahydroisoquinolines.
    Costall B; Naylor RJ
    J Med Chem; 1977 Feb; 20(2):190-6. PubMed ID: 556776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the ability of N-chloroethyl aporphine derivatives to cause irreversible inhibition of dopamine receptor mechanisms.
    Costall B; Fortune DH; Granchelli FE; Law SJ; Naylor RJ; Neumeyer JL; Nohria V
    J Pharm Pharmacol; 1980 Aug; 32(8):571-6. PubMed ID: 6106696
    [No Abstract]   [Full Text] [Related]  

  • 4. Aporphines. 14 Dopaminergic and antinociceptive activity of aporphine derivatives. Synthesis of 10-hydroxyaporphines and 10-hydroxy-N-n-propylnoraporphine.
    Neumeyer JL; Reinhard JF; Dafeldecker WP; Guarino J; Kosersky DS; Fuxe K; Agnati L
    J Med Chem; 1976 Jan; 19(1):25-9. PubMed ID: 942751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation by the aporphine derivatives of the stereotypic and hyperactivity responses resulting from injections into the nucleus accumbens septi.
    Costall B; Naylor RJ; Neumeyer JL
    J Pharm Pharmacol; 1975 Nov; 27(11):875-7. PubMed ID: 1503
    [No Abstract]   [Full Text] [Related]  

  • 6. Aporphines. 8. Total synthesis and pharmacological evaluation of (plus or minus)-apomorphine, (plus or minus)-apocodeine, (plus or minus)-N-n-propylnorapomorphine, and (plus or minus)-N-n-propylnorapocodeine.
    Neumeyer JL; Neustadt BR; Oh KH; Weinhardt KK; Boyce CB; Rosenberg FJ; Teiger DG
    J Med Chem; 1973 Nov; 16(11):1223-8. PubMed ID: 4201182
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
    Gao Y; Zong R; Campbell A; Kula NS; Baldessarini RJ; Neumeyer JL
    J Med Chem; 1988 Jul; 31(7):1392-6. PubMed ID: 3385732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain.
    Miller RJ; Kelly PH; Neumeyer JL
    Eur J Pharmacol; 1976 Jan; 35(1):77-83. PubMed ID: 943290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of telencephalic dopaminergic systems in the mediation of apomorphine-stereotyped behaviour.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1973 Oct; 24(1):8-24. PubMed ID: 4796448
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas.
    Costall B; Naylor RJ; Neumeyer JL
    Eur J Pharmacol; 1975 Mar; 31(1):1-16. PubMed ID: 1168579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of agents for stimulation of neostriatal dopaminergic mechanisms.
    Costall B; Naylor RJ; Pinder RM
    J Pharm Pharmacol; 1974 Oct; 26(10):753-6. PubMed ID: 4156532
    [No Abstract]   [Full Text] [Related]  

  • 12. Behavioral activity of some novel aporphines in rats with 6-hydroxydopamine lesions of caudate or nucleus accumbens.
    Jackson EA; Neumeyer JL; Kelly PH
    Eur J Pharmacol; 1983 Jan; 87(1):15-23. PubMed ID: 6404639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-Hydroxydopamine lesions of olfactory tubercles and caudate nuclei: effect on amphetamine-induced stereotyped behavior in rats.
    Asher IM; Aghajanian GK
    Brain Res; 1974 Dec; 82(1):1-12. PubMed ID: 4373138
    [No Abstract]   [Full Text] [Related]  

  • 14. Aporphines, 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphines.
    Neumeyer JL; Arana GW; Law SJ; Lamont JS; Kula NS; Baldessarini RJ
    J Med Chem; 1981 Dec; 24(12):1440-5. PubMed ID: 7310821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic aporphine alkaloids are potential therapeutics for Leigh syndrome.
    Kobayashi M; Miyauchi A; Jimbo EF; Oishi N; Aoki S; Watanabe M; Yoshikawa Y; Akiyama Y; Yamagata T; Osaka H
    Sci Rep; 2024 May; 14(1):11561. PubMed ID: 38773300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening nornuciferine derivatives for apomorphine-like activity.
    Burkman AM; Cannon JG
    J Pharm Sci; 1972 May; 61(5):813-4. PubMed ID: 5035801
    [No Abstract]   [Full Text] [Related]  

  • 17. Centrally acting emetics. 7. Hofmann and Emde degradation products of apomorphine.
    Cannon JG; Borgman RJ; Aleem MA; Long JP
    J Med Chem; 1973 Mar; 16(3):219-24. PubMed ID: 4738980
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and biological activity of (6aS)-10,11-dihydroxyaporphine, the optical antipode of apomorphine.
    Saari WS; King SW
    J Med Chem; 1973 Feb; 16(2):171-2. PubMed ID: 4683115
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of aporphine and emetine alkaloids on central dopaminergic mechanisms in rats.
    Lal S; Sourkes TL; Missala K; Belendiuk G
    Eur J Pharmacol; 1972 Oct; 20(1):71-9. PubMed ID: 4674034
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroleptic-like, anticonvulsant and antinociceptive effects of aporphine alkaloids: bulbocapnine, corytuberine, boldine and glaucine.
    Zetler G
    Arch Int Pharmacodyn Ther; 1988; 296():255-81. PubMed ID: 2907279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.